Home
Pharma News
CDM
Clinical Research
Medical Writing
Regulatory Affairs
More
Clinical coding (Medical)
Clinical Research Associate
Centralized Monitoring
HEOR (Health Economics and Outcome Research)
Pharmacovigilanc​e
Scientific Writing
Other
About us
Search
CLINSQUARE: CLINICAL RESEARCH COURSES
Sunday, June 8, 2025
Home
Pharma News
CDM
Clinical Research
Medical Writing
Regulatory Affairs
More
Clinical coding (Medical)
Clinical Research Associate
Centralized Monitoring
HEOR (Health Economics and Outcome Research)
Pharmacovigilanc​e
Scientific Writing
Other
About us
Facebook
Twitter
CLINSQUARE: Clinical Rsearch Courses by LIFEPRONOW
Home
Pharma News
CDM
Clinical Research
Medical Writing
Regulatory Affairs
More
Clinical coding (Medical)
Clinical Research Associate
Centralized Monitoring
HEOR (Health Economics and Outcome Research)
Pharmacovigilanc​e
Scientific Writing
Other
About us
Search
Home
Latest Pharma-News
Latest Pharma-News
Latest Pharma-News
Novartis Pluvictoâ„¢ demonstrates statistically significant and clinically meaningful rPFS benefit in patients with PSMA-positive metastatic hormone-sensitive prostate cancer
admin
-
June 4, 2025
Latest Pharma-News
FDA Launches Agency-Wide AI Tool to Optimize Performance for the American People
admin
-
June 4, 2025
Latest Pharma-News
J&J announced Icotrokinra results show 75% of adolescents with plaque psoriasis achieved completely clear skin
admin
-
April 11, 2025
Latest Pharma-News
Sanofi’s Tolebrutinib phase 3 data published in NEJM demonstrate benefit on disability progression in multiple sclerosis
admin
-
April 9, 2025
Latest Pharma-News
Novartis receives FDA accelerated approval for Vanrafia for proteinuria reduction in primary IgA nephropathy
admin
-
April 9, 2025
Latest Pharma-News
Heroic-Faith Medical Science expects US FDA clearance for AI-powered respiratory monitor
admin
-
January 20, 2020
0
Latest Pharma-News
WuXi Biologics and Bayer jointly Enter into an Acquisition Agreement on a Drug Product Plant in Germany
admin
-
January 17, 2020
0
Latest Pharma-News
TG Therapeutics Initiates Rolling Submission of NDA to U.S. FDA for Umbralisib as a Treatment for Patients with Previously Treated Marginal Zone Lymphoma or...
admin
-
January 17, 2020
0
Latest Pharma-News
FDA Grants Fast Track Designation to Arena Pharmaceuticals’ APD418 for Development for the treatment Decompensated Heart Failure Patients
admin
-
January 17, 2020
0
Latest Pharma-News
The U.S. FDA is alertes safety clinical trial shows possible increased risk of cancer with weight-loss medicine Belviq, Belviq XR (lorcaserin)
admin
-
January 17, 2020
0
Latest Pharma-News
Bristol-Myers Squibb Company announced U.S. FDA accepted its supplemental Biologics License Application (sBLA) for Opdivo (nivolumab) plus Yervoy (ipilimumab) for first-line...
admin
-
January 16, 2020
0
Latest Pharma-News
Imago Receives Fast Track Designation from U.S. FDA for Bomedemstat for the Treatment of Essential Thrombocythemia
admin
-
January 16, 2020
0
Latest Pharma-News
MorphoSys and Incyte Sign Global Collaboration and License Agreement for Tafasitamab development for the treatment of the B cell malignancies
admin
-
January 16, 2020
0
Latest Pharma-News
CytoDyn Files for Breakthrough Therapy Designation with the FDA for the Use of Leronlimab as an adjuvant therapy for the Treatment of Metastatic Triple-Negative...
admin
-
January 16, 2020
0
Latest Pharma-News
Ultragenyx and Kyowa Kirin Announce Submission of Supplemental Biologics License Application to U.S. FDA for Crysvita® (burosumab) for the treatment of Tumor-Induced Osteomalacia (TIO)
admin
-
January 16, 2020
0
Latest Pharma-News
BioCryst to Provide Berotralstat and BCX9930 Program Updates at 38th Annual J.P. Morgan Healthcare Conference
admin
-
January 13, 2020
0
Latest Pharma-News
FDA grants breakthrough device designation to Reflow Medical’s temporary spur stent system for the treatment of below-the-knee (BTK) peripheral artery disease
admin
-
January 13, 2020
0
1
...
133
134
135
...
145
Page 134 of 145
- Advertisment -
Most Read
Novartis Pluvictoâ„¢ demonstrates statistically significant and clinically meaningful rPFS benefit in patients with PSMA-positive metastatic hormone-sensitive prostate cancer
June 4, 2025
FDA Launches Agency-Wide AI Tool to Optimize Performance for the American People
June 4, 2025
J&J announced Icotrokinra results show 75% of adolescents with plaque psoriasis achieved completely clear skin
April 11, 2025
Sanofi’s Tolebrutinib phase 3 data published in NEJM demonstrate benefit on disability progression in multiple sclerosis
April 9, 2025